Building upon this concept, CAR-T cells engineered to secrete PD-1-blocking scFvs within the TME enhanced the survival of PD-L1-tumor-bearing mice in syngeneic and xenogeneic mouse models [121]. This evidence concerns the gene CD274 and neoplasm.